Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
300841.SZ Stock Price Chart
Explore Chengdu Kanghua Biological Products Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300841.SZ price movements and trends.
300841.SZ Company Profile
Discover essential business fundamentals and corporate details for Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Jun 2020
Employees
620.00
Website
https://www.kangh.comCEO
Wennian Wu
Description
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservatives, which completed phase III clinical trials; and human H5N1 influenza vaccine that completed pre-clinical studies. In addition, it exports its products. The company was founded in 2004 and is based in Chengdu, China.
300841.SZ Financial Timeline
Browse a chronological timeline of Chengdu Kanghua Biological Products Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 20 May 2025
A dividend of ¥1.00 per share was announced, adjusted to ¥1.00. The dividend was paid on 20 May 2025.
Earnings released on 22 Apr 2025
EPS came in at ¥0.16 , while revenue for the quarter reached ¥137.94M .
Earnings released on 18 Apr 2025
EPS came in at -¥0.06 , while revenue for the quarter reached ¥371.50M .
Earnings released on 28 Oct 2024
EPS came in at ¥0.77 , while revenue for the quarter reached ¥319.29M .
Earnings released on 17 Aug 2024
EPS came in at ¥1.19 , while revenue for the quarter reached ¥425.89M .
Dividend declared on 8 May 2024
A dividend of ¥2.00 per share was announced, adjusted to ¥2.00. The dividend was paid on 8 May 2024.
Earnings released on 23 Apr 2024
EPS came in at ¥1.12 , while revenue for the quarter reached ¥309.93M .
Earnings released on 30 Mar 2024
EPS came in at ¥1.02 , while revenue for the quarter reached ¥583.48M .
Earnings released on 20 Oct 2023
EPS came in at ¥0.90 , while revenue for the quarter reached ¥355.62M .
Earnings released on 22 Aug 2023
EPS came in at ¥1.07 , while revenue for the quarter reached ¥356.33M .
Dividend declared on 24 May 2023
A dividend of ¥0.50 per share was announced, adjusted to ¥0.50. The dividend was paid on 24 May 2023.
Earnings released on 24 Apr 2023
EPS came in at ¥0.79 , while revenue for the quarter reached ¥278.11M .
Earnings released on 29 Mar 2023
EPS came in at ¥0.86 , while revenue for the quarter reached ¥392.18M .
Earnings released on 24 Oct 2022
EPS came in at ¥1.25 , while revenue for the quarter reached ¥394.78M .
Earnings released on 22 Aug 2022
EPS came in at ¥1.35 , while revenue for the quarter reached ¥393.03M .
Dividend declared on 25 May 2022
A dividend of ¥2.25 per share was announced, adjusted to ¥1.50. The dividend was paid on 25 May 2022.
Stock split effective on 25 May 2022
Shares were split 3 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 21 Apr 2022
EPS came in at ¥1.01 , while revenue for the quarter reached ¥503.79M , missing expectations by -73.49%.
Earnings released on 31 Mar 2022
EPS came in at ¥1.01 , while revenue for the quarter reached ¥266.74M .
Earnings released on 25 Oct 2021
EPS came in at ¥2.45 , while revenue for the quarter reached ¥228.25M .
Earnings released on 2 Aug 2021
EPS came in at ¥2.51 , while revenue for the quarter reached ¥323.26M .
Dividend declared on 27 May 2021
A dividend of ¥1.50 per share was announced, adjusted to ¥0.67. The dividend was paid on 27 May 2021.
Stock split effective on 27 May 2021
Shares were split 3 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 20 Apr 2021
EPS came in at ¥0.40 , while revenue for the quarter reached ¥213.60M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.74 , while revenue for the quarter reached ¥237.15M .
Earnings released on 22 Oct 2020
EPS came in at ¥1.19 , while revenue for the quarter reached ¥370.12M .
300841.SZ Stock Performance
Access detailed 300841.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.